Blue Owl Capital Holdings LP 13F Portfolio
| Entity | Category | QoQ AUM Change | AUM (13F) | # of Holdings | Performance Rank | Equities Trend |
|---|---|---|---|---|---|---|
BO Blue Owl Capital Holdings LP | Institutional Filer | ▼ 72.15% | $372.2M | 75 |
Current Portfolio Holdings
Showing all 75 reported positions by value
| # | Stock | Company Name | Sector | Shares Held | Market Value | % of Portfolio |
|---|---|---|---|---|---|---|
| 1 | AKTS | AKTIS ONCOLOGY INC | — | 3.2M | $56.6M | 15.20% |
| 2 | LRMR | Larimar Therapeutics, Inc. | Healthcare | 7.1M | $32.0M | 8.61% |
| 3 | ENGN | enGene Holdings Inc. | Healthcare | 4.4M | $30.1M | 8.08% |
| 4 | NCDL | Nuveen Churchill Direct Lending Corp. | Financial Services | 2.1M | $27.3M | 7.33% |
| 5 | CGEM | Cullinan Therapeutics, Inc. | Healthcare | 1.9M | $27.1M | 7.29% |
| 6 | OBDC | Blue Owl Capital Corporation | Financial Services | 2.0M | $22.6M | 6.08% |
| 7 | MPLT | MapLight Therapeutics, Inc. | — | 1.0M | $20.5M | 5.49% |
| 8 | CMPX | Compass Therapeutics, Inc. | Healthcare | 2.9M | $15.6M | 4.18% |
| 9 | CNTX | Context Therapeutics Inc. | Healthcare | 5.1M | $13.3M | 3.58% |
| 10 | HLLY | Holley Inc. | Consumer Cyclical | 4.2M | $13.0M | 3.49% |
| 11 | EYPT | EyePoint Pharmaceuticals, Inc. | Healthcare | 913K | $11.8M | 3.16% |
| 12 | CRVS | Corvus Pharmaceuticals, Inc. | Healthcare | 545K | $8.0M | 2.14% |
| 13 | CNDT | Conduent Incorporated | Technology | 5.0M | $6.4M | 1.73% |
| 14 | RARE | Ultragenyx Pharmaceutical Inc. | Healthcare | 303K | $6.3M | 1.70% |
| 15 | AQST | Aquestive Therapeutics, Inc. | Healthcare | 1.3M | $5.6M | 1.50% |
Showing 1 to 15 of 75 holdings